Skip to main content
Clinical Trials/NCT03836248
NCT03836248
Recruiting
Not Applicable

Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain

Clinique Pasteur1 site in 1 country199 target enrollmentOctober 2, 2019

Overview

Phase
Not Applicable
Intervention
Current practice Medication treatment
Conditions
Chronic Low Back Pain
Sponsor
Clinique Pasteur
Enrollment
199
Locations
1
Primary Endpoint
Pain VAS Visual Analog Scale
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

The management of chronic low back pain is now part of a multi-disciplinary set of proposals with the aim of adapting for each patient orientations of both medicated and non-medicated care.

Very classically, analgesic treatment of stage I or II is of use, reinforced by the occasional use of NSAIDs in the absence of contraindication. In this medical attempt of the control of the pain associates a physical care (supervised exercises, physiotherapy care), cognitive and behavioral therapy, multidisciplinary care.

Osteopathic treatment is a specific manual diagnostic and therapeutic procedure.

This study aims to evaluate the relevance of providing osteopathic treatment in combination with classical medical treatment in the management of patients with chronic non-specific low back pain.

Detailed Description

The primary objective is to show that the addition of osteopathic treatment to classical medical treatment decreases pain for patients with chronic nonspecific low back pain. This goal will be evaluated at 3 months by comparing * the 3-month change in the level of pain observed in arm 3 (classical medical treatment + osteopathic treatment) versus that observed in arm 1 (classical medical treatment), and * the 3-month change in the level of pain observed in arm 3 (classical medical treatment + osteopathic treatment) versus that observed in arm 2 (classical medical treatment+ sham osteopathic treatment ).

Registry
clinicaltrials.gov
Start Date
October 2, 2019
End Date
September 1, 2028
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor
Principal Investigator

Barthélémy de Truchis

Principal investigator, MD

Clinique Pasteur

Eligibility Criteria

Inclusion Criteria

  • Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months.
  • Patient affiliated with a social security scheme or equivalent
  • Patient having signed the study informed consent form.

Exclusion Criteria

  • Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing.
  • Patient following a treatment of the Morphinic or Neuroleptic type.
  • Pregnant, breastfeeding or parturient woman
  • Patient participating in another clinical study
  • Protected patient: Major under some form of guardianship ; Hospitalized without consent

Arms & Interventions

1-Current practice Medication treatment

Medication treatment according to current practice.

Intervention: Current practice Medication treatment

2- Sham osteopathic treatment

Medication treatment according to current practice + sham osteopathic treatment.

Intervention: Sham osteopathic treatment

2- Sham osteopathic treatment

Medication treatment according to current practice + sham osteopathic treatment.

Intervention: Current practice Medication treatment

3- Osteopathic treatment

Medication treatment according to current practice + osteopathic treatment.

Intervention: Osteopathic treatment

3- Osteopathic treatment

Medication treatment according to current practice + osteopathic treatment.

Intervention: Current practice Medication treatment

Outcomes

Primary Outcomes

Pain VAS Visual Analog Scale

Time Frame: Change from baseline to 3 months

The primary outcome is the change in the VAS score on a 0-100 mm scale between Day 0 (before the placement of any osteopathic manipulations for Arm 3 ( or sham osteopathic treatment for Arm 2) and J90 ( after the last osteopathic treatment session for Arm 3 (sham osteopathic treatment for Arm 2)).

Secondary Outcomes

  • Pain VAS , level improvement(Baseline, Day 15, Month 1, Month 2, Month 3, Month 6)
  • Hand-Ground Distance and Schöber test(Baseline, Day 15, Month 1, Month 2, Month 3, Month 6)
  • Adverse event(Day 15, Month 1, Month 2, Month 3, Month 6)
  • Drug consumption(Baseline, Day 15, Month 1, Month 2, Month 3, Month 6)
  • Relief Numerical scale(Day 15, Month 1, Month 2, Month 3, Month 6)
  • Elements of the osteopathic diagnosis(Day 1, Day 7, Day 15, Month 1 Month 2)
  • Oswestry score(Baseline, Day 15, Month 1, Month 2, Month 3, Month 6)

Study Sites (1)

Loading locations...

Similar Trials